Literature DB >> 22941468

Differential gene expression of Wnt signaling pathway in benign, premalignant, and malignant human breast epithelial cells.

Yu-Zhou Wang1, Yu-Song Han, Yu-Shui Ma, Jun-Jian Jiang, Zi-Xian Chen, Yi-Chao Wang, Wu Che, Feng Zhang, Qing Xia, Xiao-Feng Wang.   

Abstract

To gain insight into the role of gene expression alterations in breast cancer progression, we conducted a comprehensive gene expression analysis of a series of cell lines derived from MCF10A, which include benign MCF10A cells, premalignant AT, and malignant CA1a tumor cells. We analyzed gene expression variation using the Agilent Human Genome Oligo Microarray with the goal of identifying gene-specific expression change events. In addition to a previously noted overexpression in oncogene MDM2, HRAS, and PCNA, our studies identified overexpression of Wnt signaling pathway in malignant breast cell lines. The Kaplan-Meier plot showed that high c-Myc expression in breast cancer was associated with tumor progression and the patient's poor survival. This study showed that the Wnt pathway has further provided a basis for the development of potential biomarker for breast cancer prognosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22941468     DOI: 10.1007/s13277-012-0494-0

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  18 in total

Review 1.  WNT signalling in the immune system: WNT is spreading its wings.

Authors:  Frank J T Staal; Tiago C Luis; Machteld M Tiemessen
Journal:  Nat Rev Immunol       Date:  2008-08       Impact factor: 53.106

Review 2.  Developing gene expression signatures of pathway deregulation in tumors.

Authors:  James W Watters; Christopher J Roberts
Journal:  Mol Cancer Ther       Date:  2006-10       Impact factor: 6.261

3.  Progression of premalignant MCF10AT generates heterogeneous malignant variants with characteristic histologic types and immunohistochemical markers.

Authors:  L B Strickland; P J Dawson; S J Santner; F R Miller
Journal:  Breast Cancer Res Treat       Date:  2000-12       Impact factor: 4.872

4.  Wnt5a participates in hepatic stellate cell activation observed by gene expression profile and functional assays.

Authors:  Wu-Jun Xiong; Li-Juan Hu; Yi-Cheng Jian; Li-Jing Wang; Ming Jiang; Wei Li; Yi He
Journal:  World J Gastroenterol       Date:  2012-04-21       Impact factor: 5.742

5.  WNT7A regulates tumor growth and progression in ovarian cancer through the WNT/β-catenin pathway.

Authors:  Shin Yoshioka; Mandy L King; Sophia Ran; Hiroshi Okuda; James A MacLean; Mary E McAsey; Norihiro Sugino; Laurent Brard; Kounosuke Watabe; Kanako Hayashi
Journal:  Mol Cancer Res       Date:  2012-01-09       Impact factor: 5.852

6.  Human breast fibroblasts inhibit growth of the MCF10AT xenograft model of proliferative breast disease.

Authors:  Andrea Sadlonova; Shibani Mukherjee; Damon B Bowe; Sandra R Gault; Nicole A Dumas; Brian A Van Tine; Natalya Frolova; Grier P Page; Danny R Welch; Lea Novak; Andra R Frost
Journal:  Am J Pathol       Date:  2007-03       Impact factor: 4.307

7.  Delineating genetic alterations for tumor progression in the MCF10A series of breast cancer cell lines.

Authors:  Mitsutaka Kadota; Howard H Yang; Bianca Gomez; Misako Sato; Robert J Clifford; Daoud Meerzaman; Barbara K Dunn; Lalage M Wakefield; Maxwell P Lee
Journal:  PLoS One       Date:  2010-02-15       Impact factor: 3.240

8.  MCF10AT: a model for the evolution of cancer from proliferative breast disease.

Authors:  P J Dawson; S R Wolman; L Tait; G H Heppner; F R Miller
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

Review 9.  Wnt-related molecules and signaling pathway equilibrium in hematopoiesis.

Authors:  Sachin Malhotra; Paul W Kincade
Journal:  Cell Stem Cell       Date:  2009-01-09       Impact factor: 24.633

10.  A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation.

Authors:  Angelika Brekman; Kathryn E Singh; Alla Polotskaia; Nandini Kundu; Jill Bargonetti
Journal:  Breast Cancer Res       Date:  2011-01-11       Impact factor: 6.466

View more
  4 in total

1.  MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.

Authors:  Samira Mohammadi-Yeganeh; Mahdi Paryan; Ehsan Arefian; Mohammad Vasei; Hossein Ghanbarian; Reza Mahdian; Morteza Karimipoor; Masoud Soleimani
Journal:  Tumour Biol       Date:  2016-01-12

2.  Gene expression profile analysis of Manila clam (Ruditapes philippinarum) hemocytes after a Vibrio alginolyticus challenge using an immune-enriched oligo-microarray.

Authors:  Rebeca Moreira; Massimo Milan; Pablo Balseiro; Alejandro Romero; Massimiliano Babbucci; Antonio Figueras; Luca Bargelloni; Beatriz Novoa
Journal:  BMC Genomics       Date:  2014-04-07       Impact factor: 3.969

Review 3.  Aberrant WNT/CTNNB1 Signaling as a Therapeutic Target in Human Breast Cancer: Weighing the Evidence.

Authors:  Emma H van Schie; Renée van Amerongen
Journal:  Front Cell Dev Biol       Date:  2020-01-31

4.  Hormesis Effect of Methyl Triclosan on Cell Proliferation and Migration in Human Hepatocyte L02 Cells.

Authors:  Jing An; Weiwei Yao; Waner Tang; Jingjing Jiang; Yu Shang
Journal:  ACS Omega       Date:  2021-07-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.